PubMed

Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes.

Huang ES, Brown SE, Thakur N, Carlisle L, Foley E, Ewigman B, Meltzer DO.

Diabetes Care. 2009 Feb;32(2):311-6. Epub 2008 Nov 18.PMID: 19017766 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes.

Harris MI.

Diabetes Care. 2001 Mar;24(3):454-9.PMID: 11289467 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study.

Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D.

Arch Intern Med. 2007 Sep 24;167(17):1853-60.PMID: 17893306 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.

Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH.

BMC Health Serv Res. 2006 May 23;6:58.PMID: 16716235 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS.

Diabetes Care. 1999 Mar;22(3):403-8.PMID: 10097918 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethnic disparities in glycemic control among rural older adults with type 2 diabetes.

Quandt SA, Bell RA, Snively BM, Smith SL, Stafford JM, Wetmore LK, Arcury TA.

Ethn Dis. 2005 Autumn;15(4):656-63.PMID: 16259490 [PubMed - indexed for MEDLINE]Related articlesFree article

Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Gellad WF, Haas JS, Safran DG.

J Gen Intern Med. 2007 Nov;22(11):1572-8. Epub 2007 Sep 20.PMID: 17882499 [PubMed - indexed for MEDLINE]Related articlesFree article

The association between diabetes metabolic control and drug adherence in an indigent population.

Schectman JM, Nadkarni MM, Voss JD.

Diabetes Care. 2002 Jun;25(6):1015-21.PMID: 12032108 [PubMed - indexed for MEDLINE]Related articlesFree article

The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients.

Cooper LA, Gonzales JJ, Gallo JJ, Rost KM, Meredith LS, Rubenstein LV, Wang NY, Ford DE.

Med Care. 2003 Apr;41(4):479-89.PMID: 12665712 [PubMed - indexed for MEDLINE]Related articles

A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

Medication adherence and racial differences in A1C control.

Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D.

Diabetes Care. 2008 May;31(5):916-21. Epub 2008 Jan 30.PMID: 18235050 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S.

J Clin Endocrinol Metab. 2009 May;94(5):1689-94. Epub 2009 Mar 10.PMID: 19276235 [PubMed - indexed for MEDLINE]Related articles

Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.

Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT.

Clin Ther. 2006 Aug;28(8):1199-207.PMID: 16982297 [PubMed - indexed for MEDLINE]Related articles

Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.

Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM.

Diabetes Care. 2008 Feb;31(2):261-6. Epub 2007 Nov 13.PMID: 18000177 [PubMed - indexed for MEDLINE]Related articlesFree article

Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors.

Ashing-Giwa KT, Padilla G, Tejero J, Kraemer J, Wright K, Coscarelli A, Clayton S, Williams I, Hills D.

Psychooncology. 2004 Jun;13(6):408-28.PMID: 15188447 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis.

Maggs D, Shen L, Strobel S, Brown D, Kolterman O, Weyer C.

Metabolism. 2003 Dec;52(12):1638-42.PMID: 14669170 [PubMed - indexed for MEDLINE]Related articles

Heterogeneity in management of diabetes mellitus among Latino ethnic subgroups in the United States.

Mainous AG 3rd, Diaz VA, Saxena S, Geesey ME.

J Am Board Fam Med. 2007 Nov-Dec;20(6):598-605.PMID: 17954868 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients.

Sheats N, Lin Y, Zhao W, Cheek DE, Lackland DT, Egan BM.

Ethn Dis. 2005 Winter;15(1):25-32.PMID: 15720046 [PubMed - indexed for MEDLINE]Related articles

Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.

Gonzalez JM, Thompson P, Escamilla M, Araga M, Singh V, Farrelly N, Thase ME, Miklowitz DJ, Bowden CL.

Psychopharmacol Bull. 2007;40(1):31-46.PMID: 17285094 [PubMed - indexed for MEDLINE]Related articles

Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).

Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA.

Diabetes Care. 1998 Apr;21(4):510-5.PMID: 9571333 [PubMed - indexed for MEDLINE]Related articlesFree article